u 74389f has been researched along with bilirubin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dwenger, A; Grotz, M; Gruner, A; Hafemann, R; Pape, HC; Regel, G; Remmers, D; Seekamp, A | 1 |
| Altavilla, D; Arlotta, M; Campo, GM; Caputi, AP; Quartarone, C; Saitta, A; Sardella, A; Squadrito, F; Squadrito, G; Urna, G | 1 |
2 other study(ies) available for u 74389f and bilirubin
| Article | Year |
|---|---|
Attenuation of multiple organ dysfunction in a chronic sheep model by the 21-aminosteroid U74389G.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Bilirubin; Bronchoalveolar Lavage Fluid; Cardiac Output; Female; Kidney; L-Iditol 2-Dehydrogenase; Leukocyte Count; Multiple Organ Failure; Neutrophils; Oxygen; Pregnatrienes; Respiratory Burst; Sheep; Shock, Hemorrhagic; Vascular Resistance | 1996 |
The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shock.
Topics: Alanine Transaminase; Animals; Antioxidants; Aorta, Thoracic; Bilirubin; Blood Pressure; Dose-Response Relationship, Drug; Endothelium, Vascular; Endotoxemia; Heart Rate; In Vitro Techniques; Lipopolysaccharides; Liver; Male; Muscle Contraction; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Phenylephrine; Pregnatrienes; Rats; Rats, Sprague-Dawley; Survival Rate; Vasoconstrictor Agents | 1999 |